Russian patients get access to first immuno-oncology drug to treat nasopharyngeal cancer
The Russian market receives the first batch of the original innovative drug Areima® (camrelizumab)
Petrovax Pharm gets the best project of the year award for its market launch of Areima®
RUSSCO includes Areima® in the most preferred first-line regimen of nasopharyngeal cancer therapy
